Pharma Focus Asia

Syneos Health Collaborates with Microsoft

Tuesday, March 21, 2023

Syneos Health® announced a strategic multi-year agreement with Microsoft. The multi-year agreement includes collaboration with Microsoft Research and leverages developments from OpenAI. Through this collaboration, Syneos Health will deliver technology and data solutions with Microsoft that accelerate clinical development and elevate commercial performance for biopharma customers.

Based on AI-enabled platform, Syneos Health will be able to process and analyse data to fast-track timelines, optimise resource allocation and unlock clinical trial efficiencies. These capabilities will allow for superior site selection and reduced enrolment timelines to bring new treatments to patients faster. Syneos Health combines AI expertise with solutions that help make a big difference in patients' lives.

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024